Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
391.3500 -1.60 (-0.41%)
NSE Jan 05, 2026 15:59 PM
Volume: 1.5M
 

logo
Biocon Ltd.
02 Nov 2020
391.35
-0.41%
Axis Direct
Biocon Ltd is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immune suppressants and anti-diabetic drugs.
Biocon Ltd. has an average target of 376.40 from 5 brokers.
More from Biocon Ltd.
Recommended